SUN PHARMA UK LIMITED

1. SUN PHARMA UK LIMITED 2022-02-21 → present
2. RANBAXY (U.K.) LIMITED 1994-11-21 → 2022-02-21

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 102

Reporting scope

Standalone (parent only)

Auditor

PBG Associates Limited

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“The company has sufficient current assets to cover its liabilities. As a consequence, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The directors have considered the impact of the Covid-19 pandemic, and the measures taken to contain it, on the company and because of the nature of the company's activities they do not consider that there will be any significant effect on the ability of the company to continue in business and meet its liabilities as they fall due. Thus, they continue to adopt the going concern basis of accounting in preparing the annual financial statements.”

Significant events

• “On March 25, 2021, the Court of Justice of the European Union ( CJEU ) issued a final judgment and upheld the fine against Sun Pharma UK Limited (erstwhile known as Ranbaxy (U.K.) Limited) in full and ruled that the European Commission's ( EC ) decision dated June 19, 2013 that a settlement agreement between Ranbaxy and Lundbeck had been anti-competitive. The Company may now be subject to "follow-on" claims in national courts of some countries in Europe. The Company has recently been served with a claim in the United Kingdom, however the claim does not currently detail how the quantum of any purported damages is carved out between the various defendants. Accordingly, the Company is currently unable to estimate the potential liability which may arise on account of follow-on claims. The Company also believes, based on its internal assessment and that of its independent legal counsel, that it has favourable legal arguments in terms of defending the relevant claim and any potential future damages claim.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

2

last 12 months

Capital events

0

last 24 months

Officers appointed

0

last 12 months

Officers resigned

0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

• Turnover

  +3.6%

  £50,705,272 → £52,527,284

• Cash

  +57.5%

  £3,455,228 → £5,441,428

• Net assets

  +5.2%

  £19,431,968 → £20,449,875

• Employees

  0%

  21 → 21

• Operating profit

  +47.2%

  £808,410 → £1,189,883

• Profit before tax

  +46%

  £931,328 → £1,359,847

• Wages

  +15.1%

  £1,579,687 → £1,818,754

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers